A61K8/985

THERAPEUTIC COMPOSITIONS AND METHODS USING EXOSOMES DERIVED FROM HUMAN DERMAL FIBROBLASTS
20210186831 · 2021-06-24 ·

The present disclosure provides compositions and methods relating to the use of exosomes derived from human dermal fibroblasts (HDFs). In particular, the present disclosure provides novel compositions and methods for generating and maintaining exosomes derived from HDF spheroids, as well as compositions and methods for delivering the exosomes to a subject for various therapeutic purposes, such as the treatment of skin conditions.

Toothpaste for delivery of allergens to oral mucosa
10967059 · 2021-04-06 · ·

Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.

Bioassimilable protein-melanin complex, preparation and uses

The present invention relates to a bioassimilable protein-melanin complex, advantageously soluble in water, comprising a protein extract, advantageously rich in S-sulfonated residues and melanin. The claimed complex further exhibits subsequent good assimilation in the human body. The invention also relates to a method for preparing the claimed bioassimilable protein-melanin complex, use of said complex and compositions containing at least said complex.

NANOPARTICLES AS DELIVERY VEHICLES OF ACTIVE INGREDIENTS AND METHODS FOR THE PRODUCTION THEREOF

A nanoparticle comprising a keratin polypeptide and at least one lipophilic active ingredient, wherein the at least one lipophilic active ingredient is non-covalently bound to the keratin polypeptide and can be e.g. a therapeutic or diagnostic agent, a nutraceutical, a cosmetic ingredients, a dye or a cosmeceutical, the keratin polypeptide being water-soluble; optionally, the nanoparticle further comprises at least one hydrophilic active ingredient non-covalently bound to the keratin polypeptide, which can be e.g. a therapeutic or diagnostic agent, a nutraceutical, a cosmetic ingredients, a dye or a cosmeceutical.

METHOD FOR DIRECT REPROGRAMMING OF URINE CELLS INTO KERATINOCYTE STEM CELLS AND METHOD FOR PREPARING COMPOSITION FOR PROMOTING SKIN REGENERATION USING REPROGRAMMED KERATINOCYTE STEM CELLS

The present invention relates to a method for inducing reprogramming of urine cells into keratinocyte stem cells by introducing reprogramming factors Bmi1 and dNP63a, and a composition for promoting skin regeneration which includes an induced reprogrammed keratinocyte stem cell conditioned medium as an active ingredient.

Toothpaste for Delivery of Allergens to Oral Mucosa
20200046828 · 2020-02-13 ·

Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.

Toothpaste for delivery of allergens to oral mucosa
10485867 · 2019-11-26 · ·

Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.

Product of and method for making chemical free human hair shakers
11951205 · 2024-04-09 · ·

A natural human shaker hair is offered to be efficiently applied to the balding spots and thinning areas of a user's scalp. The shaker hair comprises 100% natural human hairs and does not include any chemicals and/or man-made materials. The shaker hair is statically charged with negative electricity to not only allow easy application to the affected areas, but also cling to the user's scalp and existing hair. Thus, the shaker hair creates root lift and substantial kickstand support to the existing long hair of the user, and helps the user with desired styling. Further, an innovative method of making the all-natural human shaker hair is provided. The method prepares the shaker hair by cutting natural human hairs into hair granules and charging the hair granules with a charging machine. The resulting shaker hair charged with statically negative charge is placed into hair shakers and ready for use.

Toothpaste for delivering allergens to oral mucosa
11980664 · 2024-05-14 · ·

Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.

INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING
20240173115 · 2024-05-30 ·

A system and method for providing an autologous bio-filler to a patient is provided. The method includes harvesting dermal columns from a harvesting site and mincing the dermal columns into microsegments, where the microsegments form the autologous bio-filler. The method also includes injecting the autologous bio-filler into a recipient site of the patient.